<DOC>
	<DOCNO>NCT00338884</DOCNO>
	<brief_summary>A phase II study allow patient advanced kidney cancer access sunitinib malate treatment find good bad effect take 37.5 mg sunitinib malate continuous daily regimen ( per day ) one year .</brief_summary>
	<brief_title>Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Advanced kidney cancer Previous treatment kidney cancer , except surgical removal kidney tumor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>